⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 10, 2021Molecular Therapy — Methods & Clinical DevelopmentOpen Access

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes

View Full Paper

Ask AI

Bookmark

Share

Abstract

genome editing with AAV6 vectors and provide a blueprint for improving AAV6-mediated homology-directed editing of human T and B cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rogers et al. (2021) studied this question.

synapsesocial.com/papers/6a11e667157ff1551221bdcc https://doi.org/10.1016/j.omtm.2021.09.003

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical development of gene therapy: results and lessons from recent successesHuman Clinical Trial · 2016 · 237 citations
2Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor TemplatesOriginal Research · 2019 · 127 citations
3Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairOriginal Research · 2018 · 96 citations
4Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantationOriginal Research · 2020 · 72 citations
5High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In VivoIn Vitro Study · 2013 · 53 citations